Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, it added.
from Top Business News- News18.com
Read The Rest:timesnownews...
from Top Business News- News18.com
Read The Rest:timesnownews...
Biocon Gets DCGI Nod for Emergency Use of Itolizumab for Treatment of Covid-19 Patients
Reviewed by Team Exprssnews
on
July 12, 2020
Rating:
No comments: